These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3285909)

  • 21. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.
    Mitani K; Hangaishi A; Imamura N; Miyagawa K; Ogawa S; Kanda Y; Yazaki Y; Hirai H
    Leukemia; 1997 Jun; 11(6):863-5. PubMed ID: 9177441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome.
    Paquette RL; Landaw EM; Pierre RV; Kahan J; Lübbert M; Lazcano O; Isaac G; McCormick F; Koeffler HP
    Blood; 1993 Jul; 82(2):590-9. PubMed ID: 8329714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing.
    Bar-Eli M; Ahuja H; Gonzalez-Cadavid N; Foti A; Cline MJ
    Blood; 1989 Jan; 73(1):281-3. PubMed ID: 2642713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
    Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
    Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
    Ahuja HG; Foti A; Bar-Eli M; Cline MJ
    Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
    Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abnormalities of the p53, N-ras, DCC and FLT-3 genes in myelodysplastic syndromes].
    Nakamura K; Inokuchi K; Dan K
    J Nippon Med Sch; 2001 Apr; 68(2):143-8. PubMed ID: 11301359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes.
    Stephenson J; Lizhen H; Mufti GJ
    Leuk Res; 1995 Oct; 19(10):741-8. PubMed ID: 7500652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
    Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
    Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.
    Padua RA; Guinn BA; Al-Sabah AI; Smith M; Taylor C; Pettersson T; Ridge S; Carter G; White D; Oscier D; Chevret S; West R
    Leukemia; 1998 Jun; 12(6):887-92. PubMed ID: 9639416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
    Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
    Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
    Neubauer A; Dodge RK; George SL; Davey FR; Silver RT; Schiffer CA; Mayer RJ; Ball ED; Wurster-Hill D; Bloomfield CD
    Blood; 1994 Mar; 83(6):1603-11. PubMed ID: 8123851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic aspects of myelodysplastic syndromes.
    Bartram CR
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):557-70. PubMed ID: 1613006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.
    Mano H; Ishikawa F; Hirai H; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):102-6. PubMed ID: 2498243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.